Healthcare provider profile · identity verified

John P Daniels, MD

Family Practice · SALEM, OR · NPI 1518909506

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	690	195
Omeprazole	Omeprazole	445	113
Levothyroxine Sodium	Levothyroxine Sodium	416	101
Lisinopril	Lisinopril	389	107
Losartan Potassium	Losartan Potassium	380	113
Amlodipine Besylate	Amlodipine Besylate	374	100
Gabapentin	Gabapentin	280	77
Metformin Hcl	Metformin Hcl	235	71
Hydrochlorothiazide	Hydrochlorothiazide	219	69
Metoprolol Succinate	Metoprolol Succinate	218	67
Trazodone Hcl	Trazodone Hcl	212	42
Alendronate Sodium	Alendronate Sodium	185	43
Sertraline Hcl	Sertraline Hcl	171	32
Albuterol Sulfate Hfa	Albuterol Sulfate	168	54
Metoprolol Tartrate	Metoprolol Tartrate	157	45
Pravastatin Sodium	Pravastatin Sodium	156	44
Furosemide	Furosemide	154	41
Potassium Chloride	Potassium Chloride	154	42
Simvastatin	Simvastatin	152	43
Tamsulosin Hcl	Tamsulosin Hcl	151	47
Pantoprazole Sodium	Pantoprazole Sodium	135	33
Metformin Hcl Er	Metformin Hcl	128	39
Fluoxetine Hcl	Fluoxetine Hcl	125	40
Atenolol	Atenolol	117	29
Eliquis	Apixaban	114	30
Allopurinol	Allopurinol	95	24
Alprazolam	Alprazolam	91	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	91	25
Baclofen	Baclofen	88	11
Tramadol Hcl	Tramadol Hcl	87	30
Escitalopram Oxalate	Escitalopram Oxalate	84	28
Fluticasone Propionate	Fluticasone Propionate	81	22
Lovastatin	Lovastatin	79	22
Rosuvastatin Calcium	Rosuvastatin Calcium	78	27
Montelukast Sodium	Montelukast Sodium	77	22
Meloxicam	Meloxicam	74	29
Clonazepam	Clonazepam	72	14
Bupropion Xl	Bupropion Hcl	71	17
Duloxetine Hcl	Duloxetine Hcl	71	16
Clopidogrel	Clopidogrel Bisulfate	70	17
Carvedilol	Carvedilol	65	16
Citalopram Hbr	Citalopram Hydrobromide	63	19
Warfarin Sodium	Warfarin Sodium	62	18
Pioglitazone Hcl	Pioglitazone Hcl	61	21
Famotidine	Famotidine	60	18
Ropinirole Hcl	Ropinirole Hcl	60	15
Zolpidem Tartrate	Zolpidem Tartrate	58	21
Paroxetine Hcl	Paroxetine Hcl	55	11
Quetiapine Fumarate	Quetiapine Fumarate	55	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	52	suppressed
Glimepiride	Glimepiride	50	19
Bupropion Hcl Sr	Bupropion Hcl	46	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	20
Ibuprofen	Ibuprofen	45	19
Ondansetron Odt	Ondansetron	44	17
Glipizide	Glipizide	43	15
Jardiance	Empagliflozin	43	13
Levetiracetam	Levetiracetam	43	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	42	suppressed
Azithromycin	Azithromycin	42	38
Cephalexin	Cephalexin	41	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	13
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	12
Methocarbamol	Methocarbamol	37	13
Tizanidine Hcl	Tizanidine Hcl	37	11
Xarelto	Rivaroxaban	36	suppressed
Clonidine Hcl	Clonidine Hcl	35	suppressed
Olanzapine	Olanzapine	35	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	33	suppressed
Prednisone	Prednisone	33	29
Lansoprazole	Lansoprazole	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	12
Pregabalin	Pregabalin	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Estradiol	Estradiol	28	suppressed
Lorazepam	Lorazepam	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Naproxen	Naproxen	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Cholestyramine	Cholestyramine (With Sugar)	25	suppressed
Diazepam	Diazepam	25	14
Doxycycline Hyclate	Doxycycline Hyclate	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Ingrezza	Valbenazine Tosylate	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Glipizide Er	Glipizide	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	17
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Ozempic	Semaglutide	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Fosinopril Sodium	Fosinopril Sodium	22	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Risperidone	Risperidone	22	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Terbinafine Hcl	Terbinafine Hcl	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	17	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Finasteride	Finasteride	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Fenofibrate	Fenofibrate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Modafinil	Modafinil	12	suppressed
Paliperidone Er	Paliperidone	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Temazepam	Temazepam	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Carbatrol	Carbamazepine	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error